All Roll Calls
Yes: 121 • No: 7
Sponsored By: Sponsor information unavailable
Signed by Governor
Personalized for You
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
Beginning July 1, 2025, patients with life-threatening or severely debilitating illnesses can request experimental drugs, biological products, or devices made only for them using their genetic profile. A doctor must confirm the illness, review all FDA-approved options with the patient, recommend treatment, and document eligibility. Treatment must come through a facility operating under Federalwide Assurance rules for protecting human research subjects. Written consent must identify the treatment, explain approved options, state that conventional treatments are unlikely to prolong life, and describe possible outcomes, worst-case risks, and likely side effects; the patient—or a guardian or attorney-in-fact for a minor—must sign, with the doctor and a witness attesting. Tennessee officials cannot block or attempt to block access, but licensed providers can give advice that follows medical standards.
Beginning July 1, 2025, insurers, health plans, plan administrators, and government agencies can cover personalized experimental treatment and related services, but this law does not require payment. Facilities and manufacturers can offer treatment free or charge treatment and manufacturing costs. Manufacturers do not have to supply treatment, and providers do not have to supply services unless they approve the request. Required consent warns that coverage is not guaranteed without a legal or contract duty, and patients bear expenses unless another agreement says otherwise. It also warns that seeking treatment aimed at a cure may affect hospice eligibility.
Beginning July 1, 2025, heirs are not liable for unpaid personalized experimental treatment debt when the patient dies during treatment. Heirs also are not liable for lack of insurance caused by that treatment. This protection applies to those treatment-related debts and insurance consequences, not all debts the patient leaves behind.
Beginning July 1, 2025, licensing boards cannot punish providers solely for recommending personalized experimental treatment to an eligible patient. This includes suspending, revoking, or refusing to renew a license. Entities responsible for Medicare certification also cannot act against certification solely for that recommendation. The protection does not cover action based on other grounds.
Beginning July 1, 2025, required consent includes a treatment-related liability release for the treating provider, hospital, and manufacturers. The law creates no new private right to sue for treatment harm when a manufacturer or other care participant follows the law in good faith and uses reasonable care. This does not itself eliminate other existing rights to sue. Required health coverage for clinical trial participation remains unchanged.
There is no primary sponsor on record.
Janice Bowling
Republican • Senate
Rusty Crowe
Republican • Senate
Joey Hensley
Republican • Senate
Becky D. Massey
Republican • Senate
Reeves
Affiliation unavailable
Paul Rose
Republican • Senate
Stevens
Affiliation unavailable
Page Walley
Republican • Senate
Ken Yager
Republican • Senate
All Roll Calls
Yes: 121 • No: 7
Senate vote • 3/6/2025
FLOOR VOTE: as Amended Third Consideration 3/6/2025
Yes: 28 • No: 1
House vote • 3/6/2025
FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 3/6/2025
Yes: 85 • No: 5
Senate vote • 2/26/2025
SENATE HEALTH AND WELFARE COMMITTEE
Yes: 8 • No: 1
Effective date(s) 07/01/2025
Pub. Ch. 45
Signed by Governor.
Transmitted to Governor for action.
Signed by H. Speaker
Signed by Senate Speaker
Enrolled and ready for signatures
Sponsor(s) Added.
Passed H., Ayes 85, Nays 5, PNV 3
Subst. for comp. HB.
Engrossed; ready for transmission to House
Passed Senate as amended, Ayes 28, Nays 1, PNV 1
Senate adopted Amendment (Amendment 1 - SA0021)
Placed on Senate Regular Calendar for 3/6/2025
Sponsor(s) Added.
Sponsor(s) Added.
Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 8, Nays 1 PNV 0
Placed on Senate Health and Welfare Committee calendar for 2/26/2025
Sponsor(s) Added.
Passed on Second Consideration, refer to Senate Health and Welfare Committee
Introduced, Passed on First Consideration
Filed for introduction
Enrolled / Public Chapter
Fiscal Note
Introduced
SA0021
SB 0254, AN ACT to amend Tennessee Code Annotated, Title 38; Title 39; Title 40 and Title 55, relative to criminal law.
SB 0198, AN ACT to amend Tennessee Code Annotated, Title 67, relative to taxes.
HB 2670, AN ACT to amend Chapter 33 of the Private Acts of 1985; as amended by Chapter 85 of the Private Acts of 2004; and any other acts amendatory thereto, relative to the City of Gleason.
HB 2656, AN ACT to amend Chapter 325 of the Private Acts of 1945; as amended by Chapter 335 of the Private Acts of 1968; Chapter 282 of the Private Acts of 1972; Chapter 23 of the Private Acts of 1973; Chapter 93 of the Private Acts of 1983; Chapter 83 of the Private Acts of 1985; Chapter 218 of the Private Acts of 1990; Chapter 11 of the Private Acts of 1991; Chapter 65 of the Private Acts of 1993; Chapter 90 of the Private Acts of 2000; Chapter 77 of the Private Acts of 2002; Chapter 136 of the Private Acts of 2002; Chapter 27 of the Private Acts of 2011; Chapter 41 of the Private Acts of 2022; and any other acts amendatory thereto, relative to the City of Lafayette.
HB 2666, AN ACT to amend Chapter 131 of the Private Acts of 1969; as amended by Chapter 85 of the Private Acts of 1987; Chapter 74 of the Private Acts of 1995; Chapter 57 of the Private Acts of 2001 and Chapter 67 of the Private Acts of 2024; and any other acts amendatory thereto, relative to the privilege tax upon hotel occupancy in Shelby County.
HB 2631, AN ACT to make appropriations for the purpose of defraying the expenses of the state government for the fiscal years beginning July 1, 2025, and July 1, 2026, in the administration, operation and maintenance of the legislative, executive and judicial branches of the various departments, institutions, offices and agencies of the state; for certain state aid and obligations; for capital outlay, for the service of the public debt, for emergency and contingency; to repeal certain appropriations and any acts inconsistent herewith; to provide provisional continuing appropriations; and to establish certain provisions, limitations and restrictions under which appropriations may be obligated and expended. This act makes appropriations for the purposes described above for the fiscal years beginning July 1, 2025, and July 1, 2026.